Animation - TIL Cell Therapy for Melanoma

This animation provides an overview of Tumor Infiltrating Lymphocyte (TIL) Cell Therapy for melanoma. TIL Cell Therapy is a new type of immunotherapy that utilizes TIL to attack cancer cells. TIL Cell Therapy is now an FDA-approved treatment for non-uveal melanoma. In addition, researchers are conducting many clinical trials of potential new TIL treatments. TIL Cell Therapy is approved for people whose tumors have spread or cannot be surgically removed and who may have already had certain other melanoma treatments. Watch to learn how TIL Cell Therapy is prepared, how the infusion works, its effectiveness, possible side effects, and its current use in melanoma. You may want to ask your doctor if TIL Cell Therapy could be an option for you.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about melanoma which will help other patients, caregivers and families.

Other Modules:

 

This educational activity has been developed by the Melanoma Research Foundation (MRF), and Mechanisms in Medicine Inc.

This activity is supported by independent educational grants from Bristol-Myers Squibb, Foundation Medicine, Genentech, Iovance Biotherapeutics, Merck, Natera, and Novartis.

Bristol-Myers Squibb
Foundation Medicine
Genentech
Iovance
Merk
Natera
Novartis

This website is part of the Animated Patient® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.